- Home
- BRKRP
as of 10-19-2026 3:54pm EST
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
| Founded: | N/A | Country: | United States |
| Employees: | 11085 | City: | BILLERICA |
| Market Cap: | N/A | IPO Year: | 2000 |
| Target Price: | N/A | AVG Volume (30 days): | 2.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | annual |
| EPS: | -0.39 | EPS Growth: | -119.74 |
| 52 Week Low/High: | $264.30 - $484.90 | Next Earning Date: | N/A |
| Revenue: | $1,895,600,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | -1040.64 | Index: | N/A |
| Free Cash Flow: | 43.3M | FCF Growth: | N/A |
AI-Powered BRKRP Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare BRKRP vs Leading Stocks
See how BRKRP stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "BRKRP Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.